A rationale for blocking thromboinflammation in COVID-19 with Btk inhibitors

Platelets. 2020 Jul 3;31(5):685-690. doi: 10.1080/09537104.2020.1775189. Epub 2020 Jun 19.

¹ Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham , Birmingham, UK.
² Department of Medicine and Cardiovascular Institute, University of Pennsylvania , Philadelphia, Pennsylvania, USA.
³ Centre for Liver Research, Institute of Immunology and Inflammation, and National Institute for Health Research (NIHR) Birmingham Biomedical Research Centre, College of Medical and Dental Sciences, University of Birmingham , Birmingham, UK.
⁴ Centre of Membrane Proteins and Receptors, The Universities of Birmingham and Nottingham , The Midlands, UK.

No abstract available

Keywords: Btk; COVID-19; platelets; thromboinflammation.

Publication types